CORTEVA INC (CTVA)

US22052L1044 - Common Stock

57  +0.7 (+1.24%)

After market: 57 0 (0%)

Buy % Consensus

79

ChartMill assigns a Buy % Consensus number of 79% to CTVA. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 62.12. This target is 8.99% above the current price.
CTVA was analyzed by 30 analysts. The buy percentage consensus is at 79. So analysts seem to be have mildly positive about CTVA.
In the previous month the buy percentage consensus was at a similar level.
CTVA was analyzed by 30 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 57.0053.5363.2462.1270.35 - -6.09% 10.95% 8.99% 23.42%
Up and Down Grades
Date Firm Action Rating
2024-03-01 Wolfe Research Initiate Outperform
2024-02-12 Loop Capital Upgrade Hold -> Buy
2024-02-02 Exane BNP Paribas Upgrade Underperform -> Neutral
2024-02-02 Keybanc Maintains Overweight -> Overweight
2024-02-02 Oppenheimer Maintains Outperform -> Outperform
2024-02-02 RBC Capital Maintains Outperform -> Outperform
2024-02-02 Barclays Maintains Equal-Weight -> Equal-Weight
2024-02-02 Wells Fargo Maintains Overweight -> Overweight
2024-02-01 Mizuho Maintains Buy -> Buy
2024-01-29 Roth MKM Maintains Buy -> Buy
2024-01-11 UBS Maintains Buy -> Buy
2023-11-27 Berenberg Downgrade Buy -> Hold
2023-11-22 Roth MKM Maintains Buy -> Buy
2023-11-14 Barclays Downgrade Overweight -> Equal-Weight
2023-11-10 Keybanc Maintains Overweight -> Overweight
2023-11-10 RBC Capital Maintains Outperform -> Outperform
2023-11-10 Morgan Stanley Maintains Overweight -> Overweight
2023-10-30 Fermium Research Maintains Outperform -> Outperform
2023-10-30 BMO Capital Maintains Outperform -> Outperform
2023-10-30 RBC Capital Maintains Outperform -> Outperform
2023-10-24 Goldman Sachs Maintains Neutral -> Neutral
2023-10-23 Wells Fargo Maintains Overweight -> Overweight
2023-10-20 Oppenheimer Upgrade Perform -> Outperform
2023-10-10 Mizuho Maintains Buy -> Buy
2023-09-05 UBS Upgrade Neutral -> Buy
2023-08-17 Argus Research Maintains Buy -> Buy
2023-08-14 Barclays Maintains Overweight -> Overweight
2023-08-07 Mizuho Maintains Buy -> Buy
2023-08-07 Keybanc Maintains Overweight -> Overweight
2023-08-07 Wells Fargo Maintains Overweight -> Overweight